Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Regulatory News (RENE)

  • There is currently no data for RENE

Total Voting Rights

27 Dec 2006 07:01

ReNeuron Group plc27 December 2006 27 December 2006 (ReNeuron Group plc "The Company") Total Voting Rights For the purposes of the transitional provisions of the Financial ServicesAuthority's Disclosure and Transparency Rules, the Company's total issued sharecapital at the date of this notice is £1,185,241. The Company's issued share capital consists of 118,524,100 ordinary shares of 1peach, with one voting right per share. There are no shares held in treasury. The total number of voting rights in the Company is therefore 118,524,100. The above figure of 118,524,100 may be used by shareholders as the denominatorfor the calculations by which they will determine if they are required to notifytheir interest in, or a change to their interest in, the Company, under theDisclosure and Transparency Rules. For further information contact:ReNeuron Group plcMichael Hunt, CEO Tel: 44 (0)1483 302 560 Financial DynamicsDavid Yates Tel: 44 (0)20 7831 3113Nicola Daley This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Jun 200912:17 pmRNSNotice of Results
12th Jun 20092:56 pmRNSHolding(s) in Company
9th Jun 20097:00 amRNSStem cells manufacturing contract signed
21st May 20098:43 amRNSHolding(s) in Company
19th May 20091:21 pmRNSHolding(s) in Company
19th May 20091:18 pmRNSHolding(s) in Company
18th May 20091:06 pmRNSHolding(s) in Company
18th May 20097:00 amRNSFinal Closing of the Placing
14th May 20093:02 pmRNSThird Closing Of The Placing
14th May 200910:43 amRNSRegulatory update
1st May 20097:00 amRNSReN001 data to be presented at US conference
9th Apr 20097:00 amRNSSuccessful automation of stem cell manufacturing
8th Apr 20099:51 amRNSHolding(s) in Company
8th Apr 20099:43 amRNSHolding(s) in Company
7th Apr 20097:00 amRNSSecond Closing of the Placing
6th Apr 20097:00 amRNSPositive pre-clinical data with CTX stem cell line
3rd Apr 200911:19 amRNSResult of EGM and First Closing of the Placing
12th Mar 20097:00 amRNSAnnounces Fundraising and Conversion of Loan Notes
24th Feb 20094:03 pmRNSHolding(s) in Company
26th Jan 20097:00 amRNSReNeuron licenses stem cell line to BioFocus DPI
21st Jan 20097:00 amRNSReNeuron clarifies press comments
19th Jan 20094:00 pmRNSUpdate on ReNeuron's clinical trial
19th Jan 20097:00 amRNSReNeuron gains approval to commence trial
28th Nov 20087:00 amRNSInterim Results
24th Nov 20087:00 amRNSAppointment of NED
14th Nov 20083:30 pmRNSResearch Update
19th Sep 200810:46 amRNSResult of AGM
19th Sep 20087:00 amRNSAGM Statement
7th Aug 20083:33 pmRNSAnnual Report and Accounts
15th Jul 20087:00 amRNSResearch Update
24th Jun 20087:00 amRNSRe: Fund Raising
24th Jun 20087:00 amRNSFinal Results
23rd Jun 20083:38 pmRNSHolding(s) in Company
19th Jun 20084:33 pmRNSNotice of Results
11th Jun 20087:00 amRNSRe: ISSCR Conference
29th May 20087:00 amRNSRe: Contract
21st May 20087:00 amRNSNotice of US Patent Grant
20th May 200810:46 amRNSRe: UK Government Vote
23rd Apr 20087:00 amRNSResearch Update
19th Mar 20087:00 amRNSRegulatory Update
1st Feb 20087:01 amRNSResearch Update
7th Jan 20081:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20081:28 pmRNSRegulatory Update
11th Dec 20077:00 amRNSTo Present at Conference
28th Nov 200711:25 amRNSTo Present at US Conference
28th Nov 200711:13 amRNSNotice of Results
21st Nov 200711:30 amRNSResearch Update
8th Nov 20077:30 amRNSContract with ReNeuron
18th Oct 20077:01 amRNSResearch Update
6th Sep 200711:12 amRNSAGM Result

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.